Design And Development Of The Derma-Vacillation Device To Delay The Progression Of The Occurrence Of Stage One Pressure Ulcers In Low- And Middle-Income Countries.

Abstract

Pressure ulcers are a significant cause of mortality, particularly in low- and middle-income countries (LMICs). This study presents the development of a derma-vacillation device aimed at preventing pressure ulcers in LMICs, where limited access to treatment options is a challenge. The device utilizes vibration therapy and specifically targets the elbow region, known for its susceptibility to pressure ulcers. Employing a human-centered design approach, consultations were conducted with clinical personnel and engineers to ensure the device's relevance and effectiveness. Multiple prototype iterations and tests were performed, including vibration tests, battery life tests, user-based evaluations, and sound level tests. The findings from these tests informed iterative improvements and led to the development of a functional prototype. The affordability and resource limitations of LMICs were taken into consideration throughout the design process, making the device a suitable solution for these settings. This project addresses the pressing need to prevent pressure ulcers in LMICs and offers a cost-effective solution. The report provides a comprehensive overview of the team's progress, including project details, design methodology, and testing outcomes. The derma-vacillation device has the potential to significantly mitigate the burden of pressure ulcers and improve patient outcomes in LMICs. Further research and clinical trials are warranted to assess the device's efficacy and impact on pressure ulcer prevention.